Navigate to
-
Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
AAVRh74var adeno-associated virus serotype Rh74var ABSSSI acute bacterial skin and skin structure infections AChR acetylcholine receptor ADHD attention deficit hyperactivity disorder ALK anaplastic...
-
New indications for approved traditional drugs - 2025 Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* zopapogene imadenovec-drba Papzimeos Precigen...
-
New indications for approved traditional drugs - 2025 Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* mitomycin intravesical solution Zusduri Urogen...
-
Learn how Prime champions cancer care through its industry-leading solutions, clinical insights, charitable giving and volunteer efforts
PA Sub-Categories: Corporate responsibility Products Prime Article: Stories -
Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* cosibelimab-ipdl Unloxcyt Checkpoint Metastatic or locally advanced cutaneous squamous cell carcinoma IV...
-
AMCP 2026 spotlighted oncology innovation, AI, and payer strategies, with KOL insights on cost, access, and evolving managed care trends.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: In the News -
Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories